Introduction: The Evolution of Hemostatic Materials
Hemostasis-the process of stopping bleeding-is one of the most critical elements in surgical success. Since the earliest surgical procedures, clinicians have sought materials that can effectively control bleeding, shorten operation time, and reduce postoperative complications. Traditional hemostatic powders such as oxidized cellulose or gelatin-based agents once dominated the field, but modern surgical environments now demand safer, faster, and bioactive solutions.
In recent years, innovations in hemostatic technology have transformed the market landscape, shifting the focus from passive absorption to bioactive engagement with the body's natural coagulation mechanisms. These advancements not only improve clinical efficiency but also expand applicability across cardiovascular, orthopedic, hepatobiliary, and minimally invasive surgeries.
Traditional Hemostatic Powders: Effective but Limited
Traditional hemostatic agents-such as bone wax, gelatin sponges, and oxidized cellulose-were developed to provide mechanical barriers that absorb blood and promote clot formation. While effective in many scenarios, these materials often come with notable drawbacks:
Slow reaction times compared to the urgency of intraoperative bleeding.
Foreign body reactions due to animal-derived or synthetic ingredients.
Incomplete absorption, which can lead to granuloma formation or infection.
Limited efficacy in patients with coagulation disorders.
As surgical techniques evolve-especially in minimally invasive and laparoscopic procedures-surgeons increasingly require absorbable, fast-acting, and biocompatible hemostatic products that can adapt to complex surgical environments.
Emerging Bioactive Hemostatic Technologies
The new generation of bioactive hemostatic agents focuses on stimulating natural coagulation pathways rather than simply providing passive absorption. Technologies such as microporous polysaccharide particles, chitosan-based matrices, and fibrin sealants represent major breakthroughs in this field.
These advanced materials offer:
Instant blood absorption and concentration of coagulation factors at the wound site.
Activation of platelet aggregation to form stable fibrin networks.
Complete biodegradability, leaving no residue that may interfere with healing.
Broad surgical applicability, from vascular control to trauma management.
Among these innovations, Surgiclean® MPH Absorbable Hemostatic Particles stand out for their balance of performance, safety, and ease of use.
Surgiclean® MPH: The Next Step in Hemostatic Innovation
Surgiclean® MPH Absorbable Hemostatic Particles represent a patented plant-based hemostatic technology designed for modern surgical environments. Developed by Singclean Medical, Surgiclean® MPH serves as an adjunctive hemostatic device for controlling capillary, venous, and arteriolar bleeding where conventional procedures are ineffective or impractical.
Plant-Derived and Biocompatible
Unlike animal-based or thrombin-containing products, Surgiclean® MPH is made from purified potato starch through reverse phase emulsification cross-linking technology.
This process creates a microporous network structure (30.8–97 μm) that rapidly absorbs plasma, concentrates platelets, and enhances the body's natural coagulation cascade.
The material is 100% plant-based, non-pyrogenic, and free from allergens or viral risks. It is fully metabolized in vivo-degrading into water and carbon dioxide within 14 days-ensuring no residues remain.
Rapid Hemostatic Response
Once applied to a bleeding site, Surgiclean® MPH immediately absorbs water, creating a localized concentration of platelets and clotting factors. The clotting process begins within seconds, and complete hemostasis is usually achieved within one minute-a rate 2–3 times faster than many conventional hemostats.
Clinical evidence shows that Surgiclean® achieves a higher 3-minute success rate in bleeding control compared with other products, minimizing the risk of rebleeding and reducing surgical time.
Simple, Safe, and Ready to Use
Surgiclean® MPH is ready on demand-no refrigeration, no mixing, and no preparation. Surgeons simply pop the cap and apply the powder directly to the wound site, followed by light pressure with a dry gauze for 2–3 minutes.
Its simplicity is complemented by safety: with over 810,000 units used globally and no adverse events reported, Surgiclean® MPH has proven to be a reliable solution across multiple disciplines, including cardiovascular, hepatobiliary, and orthopedic surgeries.
Broad Surgical Applications
Surgiclean® MPH has demonstrated effective hemostasis in a wide range of procedures:
Cardiovascular surgery: controls oozing from vascular anastomoses.
Liver and spleen surgery: reduces bleeding from parenchymal tissue and resection sites.
Thoracic surgery: minimizes exudation and air leakage from lung tissue.
Orthopedic and trauma surgery: promotes rapid hemostasis in bone and soft tissue injuries.
Minimally invasive procedures: can be precisely delivered through CE-certified applicators (TQ series) designed for laparoscopic use.
Comparing Hemostatic Technologies: A New Standard
| Feature | Traditional Hemostatic Powders | Surgiclean® MPH Absorbable Hemostatic Particles |
|---|---|---|
| Material Source | Animal or synthetic | 100% plant-based potato starch |
| Mechanism | Passive absorption | Active coagulation enhancement |
| Time to Hemostasis | 3–5 minutes | 1 minute or less |
| Biocompatibility | Possible allergy or inflammation | Non-pyrogenic, fully degradable |
| Storage | Often requires cold chain | Room temperature, ready-to-use |
| Application Range | Limited | Broad (open and laparoscopic surgeries) |
The difference is clear: Surgiclean® MPH sets a new benchmark for what a hemostatic powder can achieve-rapid, clean, and biologically harmonious hemostasis.
Conclusion: The Future of Hemostatic Solutions
As the surgical landscape continues to evolve, hemostatic technology must balance efficacy, safety, and simplicity. The transition from traditional absorbent materials to bioactive, plant-derived agents represents a milestone in medical innovation.
For distributors, clinics, and healthcare institutions seeking reliable solutions to improve surgical outcomes, Surgiclean® MPH Absorbable Hemostatic Particles deliver both clinical performance and commercial value. With proven safety, rapid action, and global certifications, Surgiclean® positions itself as a trusted partner in advancing surgical excellence.
Cooperate with Singclean!
Discover how Surgiclean® MPH Absorbable Hemostatic Particles can enhance your surgical performance and patient safety.
Visit Surgiclean.net to learn more or become a distributor today.
Join the innovation in hemostatic technology-because every second counts in surgery.